Michael R. Kenison
On May 6, 2026, Proto Labs, Inc. (the “Company”) announced that Michael R. Kenison, Chief Operations Officer, intends to retire effective July 1, 2026.
Highest-materiality recent filing
Protolabs Q1 revenue record $139.3M (+10.4% YoY); GAAP EPS $0.33, non-GAAP $0.54
Revenue $139.3M record, up 10.4% YoY; CNC machining revenue +19.7% YoY.
Protolabs reports record Q4 revenue $136.5M, net income $6.0M; CNC machining up 25% YoY
Record Q4 revenue $136.5M (+12.1% YoY); full-year revenue $533.1M (+6.4% YoY).
Protolabs Q3 2025 record revenue $135.4M, up 7.8% YoY; EPS $0.30 GAAP, $0.47 non-GAAP
Record quarterly revenue of $135.4M, +7.8% YoY from $125.6M.
Proto Labs names Marc Kermisch CTO & AI Officer, effective Oct 13; Ryaboy departs Nov 2
Oleg Ryaboy steps down as CTO, effective November 2, 2025; receives severance per executive agreement.
Proto Labs reports record Q2 revenue of $135.1M, up 7.5% YoY; non-GAAP EPS $0.41
Revenue $135.1M (+7.5% YoY); net income $4.4M roughly flat vs prior year.
Protolabs appoints Suresh Krishna as CEO; reaffirms Q2 2025 guidance
Suresh Krishna appointed President, CEO, and director effective May 20, 2025, succeeding Robert Bodor.
Proto Labs FY2024 revenue $501M, GAAP EPS $0.66; Q4 net loss $0.4M; authorizes $100M buyback
Q4 revenue $121.8M (-2.6% YoY); net loss of $0.4M (GAAP diluted EPS -$0.02) vs net income $7.0M in Q4 2023
Protolabs Q3 revenue down 3.9% YoY to $126M; GAAP EPS $0.29, non-GAAP $0.47
Revenue $125.6M, down 3.9% YoY from record $130.7M in Q3 2023.
Proto Labs approves Germany facility closures; expects $4.5M-$6M restructuring charges
Plan closes prototype injection molding plant in Eschenlohe, Germany, and stops DMLS 3D printing in Putzbrunn.
Protolabs Q2 2024 revenue $125.6M (+2.8%); GAAP EPS $0.18 vs loss $0.01 YoY
Revenue $125.6M, up 2.8% YoY; Network revenue $24.7M, up 22.0%.
Proto Labs Q1 revenue $127.9M (+1.6% YoY); GAAP EPS $0.20, Non-GAAP EPS $0.40
Revenue $127.9M (+1.6% YoY); Protolabs Network revenue $23.9M (+38.9% YoY).
Protolabs Q4 revenue up 8.2% to $125M; record FY 2023 revenue of $504M; guides 2024 $495-$525M
Q4 2023 revenue $125.0M (+8.2% YoY); Network revenue $22.5M (+52% YoY).
Record revenue $130.7M; non-GAAP EPS $0.51; network revenue up 87% YoY
Record Q3 revenue of $130.7M, up 7.4% YoY.
Proto Labs Q2 revenue down 3.7% to $122.3M; GAAP loss $0.01, non-GAAP EPS $0.33
Revenue of $122.3M, down 3.7% YoY from $126.9M; network revenue $20.2M, up 79.3% YoY.
Proto Labs Q1 2023 revenue $125.9M (+1.4% YoY); EPS $0.10 GAAP, $0.30 non-GAAP
Revenue $125.9M, up 1.4% YoY from $124.2M.
Q4 revenue $115.6M (-6.5% YoY); full-year record $488.4M.
Proto Labs increases share repurchase authorization by $50M to $200M, extends to 2024
Board authorized increase from $150M to $200M; program extended through December 31, 2024.
Proto Labs to close Japan manufacturing facility; expects $7M-$9.5M in restructuring charges
Total restructuring charges expected $7.0M-$9.5M: severance $2.5M-$3.5M, asset write-down $3.5M-$4.5M, goodwill $1.0M-$1.5M.
Protolabs Q1 2022 revenue $124.2M (+6.9% YoY); GAAP EPS $0.19, non-GAAP EPS $0.38
Revenue $124.2M, up 6.9% from $116.1M in Q1 2021.
Proto Labs increases stock repurchase authorization by $50M to $150M total
Board approved $50M increase on Dec 8, 2021; total authorization now $150M through Dec 31, 2023.
Proto Labs reports Q3 2021 record revenue of $125.3M, up 17% YoY; EPS $0.17 GAAP
Revenue of $125.3M in Q3 2021, up 16.6% from $107.5M in Q3 2020.
Proto Labs Q2 2021 revenue $123.0M (+15.5% YoY), record revenue, EPS $0.47
Revenue $123.0M, up 15.5% YoY from $106.6M.
On May 6, 2026, Proto Labs, Inc. (the “Company”) announced that Michael R. Kenison, Chief Operations Officer, intends to retire effective July 1, 2026.
Effective May 18, 2026, Bernardo Parlange was appointed as the Company’s Chief Commercial Officer, a newly created role where Mr. Parlange will oversee the Company’s global commercial strategy, including sales, marketing, and customer success.
Robert Bodor ceased to be the President and Chief Executive Officer of the Company, effective as of May 20, 2025
Robert Bodor, who ceased to be the President and Chief Executive Officer and a director of the Company effective as of the Transition Date.
the Board of Directors (the “Board”) of the Company has appointed Suresh Krishna to serve as the Company’s President and Chief Executive Officer, effective May 20, 2025
The Board has also appointed Mr. Krishna to serve as a director of the Company
Robert Bodor, who ceased to be the President and Chief Executive Officer and a director of the Company effective as of the Transition Date.
Pursuant to the Settlement Agreement, Mr. Klaas’ termination date will be November 30, 2024 (the “Termination Date”).
On July 22, 2024, Bjoern Klaas, Vice President and General Manager of the EMEA region, exited his position as vice president and is no longer an executive officer of Proto Labs, Inc.
On June 3, 2022, Proto Labs, Inc. (the “Company”) appointed Daniel Schumacher, age 47, as Chief Financial Officer (“CFO”), effective immediately.
Upon the Effective Date, Dr. Robert Bodor, Chief Executive Officer of the Company, will serve as the interim Chief Technology Officer while the Company conducts a search for a new leader.
On March 16, 2022, Proto Labs, Inc. (the “Company”) announced that Arthur R. Baker III, Chief Technology Officer, is stepping down from his role with the Company, effective April 15, 2022 (the “Effective Date”).
Max materiality 0.75 · Median 0.60 · Most common event earnings